Shares of Nicox S.A. (OTCMKTS:NICXF – Get Free Report) passed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $0.25 and traded as low as $0.25. Nicox shares last traded at $0.25, with a volume of 500 shares changing hands.
Nicox Stock Performance
The firm’s 50 day simple moving average is $0.25 and its 200-day simple moving average is $0.31.
Nicox Company Profile
Nicox SA operates as an ophthalmology company in France and internationally. The company develops solutions to maintain vision and improve ocular health. Its lead product candidate is NCX 470, a novel nitric oxide-donating bimatoprost eye drop for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension, which is in Phase 3 clinical trial.
Featured Articles
- Five stocks we like better than Nicox
- How to Invest in the Best Canadian Stocks
- Energy Transfer: Powering Data With Dividends and Diversification
- What Are Treasury Bonds?
- Qualcomm Stock Is Coiling for a Breakout
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Receive News & Ratings for Nicox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nicox and related companies with MarketBeat.com's FREE daily email newsletter.
